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Abstract
Background: There is under-diagnosis of cardiovascular disease (CVD) in the English population, despite financial
incentives to encourage general practices to register new cases. We compared the modelled (expected) and
diagnosed (observed) prevalence of three cardiovascular conditions- coronary heart disease (CHD), hypertension
and stroke- at local level, their geographical variation, and population and healthcare predictors which might
influence diagnosis.
Methods: Cross-sectional observational study in all English local authorities (351) and general practices (8,372)
comparing model-based expected prevalence with diagnosed prevalence on practice disease registers. Spatial
analyses were used to identify geographic clusters and variation in regression relationships.
Results: A total of 9,682,176 patients were on practice CHD, stroke and transient ischaemic attack, and
hypertension registers. There was wide spatial variation in observed: expected prevalence ratios for all three
diseases, with less than five per cent of expected cases diagnosed in some areas. London and the surrounding
area showed statistically significant discrepancies in observed: expected prevalence ratios, with observed
prevalence much lower than the epidemiological models predicted. The addition of general practitioner supply as
a variable yielded stronger regression results for all three conditions.
Conclusions: Despite almost universal access to free primary healthcare, there may be significant and highly
variable under-diagnosis of CVD across England, which can be partially explained by persistent inequity in GP
supply. Disease management studies should consider the possible impact of under-diagnosis on population health
outcomes. Compared to classical regression modelling, spatial analytic techniques can provide additional
information on risk factors for under-diagnosis, and can suggest where healthcare resources may be most needed.
Background
Geographic variation in the incidence and prevalence of
CVD is a well-known phenomenon in population sur-
veys. Such variations in both CHD and stroke incidence
and prevalence are largely explained by area- and per-
son-specific factors such as population socio-economic
composition, demographic structure and ethnic diversity
[1-4], mediated through established CVD risk factors
[5]. In the case of England, this is exemplified at a
regional level by a North-South gradient in prevalence
and outcomes, with higher prevalences in the North [6].
From a health services perspective, it is important to
ensure that as high a proportion as possible of actual
cases have been diagnosed and well-managed when
secondary prevention is known to be effective, as is
the case for CVD [7]. Under-diagnosis and/or under-
treatment of CVD has been found in some previous
United Kingdom (UK) studies [8,9], but it was not possi-
ble to differentiate these causes. The recent availability
of registered prevalence, performance and outcome data
through the Quality & Outcomes Framework (QOF)
pay-for-performance programme, in which almost all
UK general practices participate, has provided accurate
counts of diagnosed disease prevalence, and assurance
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that identified CVD is being increasingly well-managed.
For example, in 2008-9, achievement by English general
practices of all the 89 QOF points available for CHD
management was 99.1 per cent [10]. The QOF also pro-
vides a financial reward for registering new cases of
disease.
However, the extent of under-diagnosis may adversely
affect population CVD outcomes. Epidemiologic models
can be used to provide estimates of expected prevalence
for small populations, using local data for known risk
factors. Such models can be used for:
• targeting case-finding initiatives, by comparing
diagnosed/observed and expected prevalence
• supporting needs assessment
• strategic planning
• underpinning commissioning of health services by
providing denominators
• health equity audit
• supporting resource allocation [11].
A recent study which compared observed (QOF-regis-
tered) and expected prevalences of CHD and hyperten-
sion suggested that under-diagnosis may vary
geographically [12]. However, the CHD model used by
the authors was derived from the General Practice
Research Database, resulting in a lack of independence
between the observed and predicted datasets. Several
disease prevalence models are now available on the
Association of Public Health Observatories’ (APHO)
website [13]. These provide independently-derived pre-
valence estimates for resident populations of English
local authority (LA), primary care trust (PCT), and prac-
tice populations, which can be compared with QOF dis-
ease registers [10]. Using these models, we investigated
the observed and expected prevalence of three cardio-
vascular conditions (CHD, hypertension and stroke) at
LA level to identify unmet population health care needs,
their geographical variation, and population and health-
care predictors which might influence diagnosis.
Methods
Data sources: registered prevalence and primary care
supply
Counts of general practice-registered, i.e. observed pre-
valence of CHD, stroke and hypertension in April 2007
were obtained from English general practice disease reg-
isters, produced for the purposes of incentivizing prac-
tices for achievement of QOF treatment targets. These
patients are clinically confirmed cases of CVD who are
receiving regular follow-up for their disease. QOF preva-
lence rates are based on total populations registered
with practices, but to compare observed prevalence with
expected prevalence estimated from resident population-
based contextual data from the Census and other
sources e.g. deprivation and proportion ethnic minority
population, we derived residence-based QOF prevalence
estimates for LAs using a lookup table - a pooled extract
of England practice registers - from the National Strate-
gic Tracing Service (now Personal Demographics Ser-
vice) which apportioned practice populations to LA
areas as at January 2006, by providing the exact number
of practice population resident in each LA [14].
We apportioned counts of CVD patients registered by
practices to LAs, in accordance with the proportion of
each practice population resident in that area, which
assumed that CVD prevalence was geographically uni-
form across a practice population (the average practice
population is only about 6,400). We divided the aggre-
gated count of CVD patients in each LA by total mid-
2006 LA population estimates to give estimated crude
prevalence, as used for QOF prevalence. Where less
than 50 patients fell into an LA, the numbers were
excluded from the look-up process. Three LAs could
not be mapped due to discrepancies between QOF and
NSTS datasets. In order to investigate the effect of
healthcare supply upon diagnosis levels we included a
measure of general practitioner availability in the form
of the number of general practitioners (GPs) per thou-
sand LA population, calculated in the same way [15].
Data sources: expected/estimated prevalence
Expected prevalence for each LA was obtained from
the APHO epidemiologic models, which are based on
the socio-demographic and behavioural characteristics
of respondents with the respective conditions in the
Health Survey for England (HSfE). To produce the
models, HSfE data for the years 2003-4 was pooled
(sample size 21,233) to increase the cases of diseases.
Surveys over this period included boosts for ethnic
minority and older people, and focused on CVD and
its risk factors. Of the respondents included, 14,574
(68.6%) were of White ethnicity, 308 were Mixed
(1.5%), 1,991 (9.4%) were Black or Black British, and
3,725 (17.5%) Asian or Asian British. The outcome
variables were patient-reported doctor-diagnosed CHD
and stroke, and for hypertension, normotensive-treated,
hypertensive-treated but uncontrolled, and hyperten-
sive-untreated groups; i.e. a combination of patient-
reported and objectively-measured variables. Patient
reports of doctor-diagnosed CHD and stroke have been
extensively validated elsewhere [16-20]. For example, in
the British Regional Heart Study, 80 per cent of men
with a GP record of angina reported their diagnosis,
and 70 per cent of men who reported an angina diag-
nosis had confirmation of this from the record review.
The prevalence of diagnosed angina in these older men
was 10.1 per cent according to self-reported history
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and 8.9 per cent according to GP record review [16].
At that time (1999) some cases, such as newly-regis-
tered patients, may not have had their diagnosis clearly
recorded in GP records.
Ordinary least-squares (OLS) logistic regression mod-
els were fitted and explanatory variables for each disease
outcome identified by reverse stepwise selection.
The baseline odds of each disease were obtained
directly from the HSfE dataset. The strength of associa-
tion between each explanatory variable and disease
caseness was then used to calculate the relative odds,
which were applied to the baseline odds to derive the
prevalence estimates for each sub-group of risk factors.
The variables which can be included in each local
model are limited by the availability of local data for
them from Census and other national sources. The
core model variables are ten-year age band, gender
(male and female), ethnicity (Asian/Asian British,
Black/Black British, White, Mixed and Other including
Chinese) and deprivation (based on Index of Multiple
Deprivation 2004 scores) [21]. In the case of CHD and
stroke, smoking prevalence is also included, and the
stroke model does not include ethnicity. The models
use 2006 mid-year quinary age-band population esti-
mates by ethnic group from the UK Office for National
Statistics (ONS), which were summed to 10-year age
bands to match the model [22]. LAs are stratified into
deprivation score bands based on cut-offs of Lower
Super Output Area quintiles - the ONS categories used
in the HSfE. Internal validation included using the
models to predict the response for each subject in the
source data, and area under the receiver operating
characteristics (AUROC) curve. AUROC curve values
were 0.834, 0.844, and 0.807 for the stroke, CHD and
hypertension models respectively. External validation
showed that prevalence gradients derived from the
models - for example with age and smoking status -
agree well with published results from population-
based studies.
In the case of the CHD and stroke models, smoking
status is also included. Local smoking prevalence esti-
mates are not available from the HSfE because of small
sample sizes, so the CHD model uses synthetic esti-
mates from the Neighbourhood Statistics website, which
are for the period 2003-2005 [23]. Model assumptions
include that the proportion of smokers, ex-smokers and
never-smokers is uniform across ethnic categories and
that the proportion of ex-smokers in each age-sex group
is constant across areas. Sensitivity analysis has shown
that varying the smoking prevalence has a very small
effect on prevalence. Further technical details of the
models are available in additional files 1 (CHD), 2
(hypertension) and 3 (stroke) in the web appendix, and
also on the APHO website [13].
Spatial analyses
Observed: expected prevalence ratios for LAs were cal-
culated in Excel 2007 and mapped using the geographic
information systems package ArcGIS 9. Two exploratory
spatial data analysis methods commonly used in geogra-
phical studies were used to investigate patterns in O:E
relationships, Local Moran’s I (LMI) analysis and geo-
graphically weighted regression (GWR). The LMI tech-
nique is used to identify geographic clusters and outliers
in data by testing for randomness in spatial distribution
across a dataset, localities with significance scores (Z
scores) greater than two standard deviations being con-
sidered to be either clusters or outliers [24]. Strongly
positive Z scores indicate statistically significant similar
values in close geographic proximity hence the presence
of a cluster; a strongly negative Z score demonstrates a
locality with a significantly dissimilar value in relation to
its neighbouring localities thus indicating an outlier.
GWR is a form of spatial statistics which disaggregates
geographic data into spatial blocks using a probability
distribution kernel, which moves from location to loca-
tion across the dataset to test for geographic variation in
regression relationships. In situations where there is
geographic variation in the strength of a regression
relationship, a phenomenon referred to as spatial non-
stationarity, the use of GWR will improve model good-
ness-of-fit to data, expressed as the trade-off between
statistical predictor bias (linked to R-squared values)
and variance (linked to degrees of freedom). In compari-
son to a classical model GWR will produce higher cor-
relation coefficients, lower residuals and higher degrees
of freedom than traditional ordinary least squares (OLS)
regression [25,26].
In this paper, we used GWR to assess whether a linear
regression relationship between observed and expected
prevalence existed and if so whether it varied in strength
over space, the purpose of which should be viewed as
distinct from that of mapping observed to expected
ratios, as the latter aims to measure equality between two
variables rather than to assess predictability of an associa-
tion. Both OLS and GWR models were run in the soft-
ware package GWR 3 to test for spatial non-stationarity.
The optimal bandwidth for the kernel was estimated
using the Akaike Information Criterion [27]. Two rounds
of regression were performed, the first a univariate
regression involving expected prevalence as the indepen-
dent variable and observed prevalence as the dependent
variable; the second bivariate including whole-time
equivalent GP supply as an additional variable.
Our research conformed to the Helsinki Declaration
http://www.wma.net/en/30publications/10policies/b3/,
and to local legislation. It did not require ethical
approval or patient consent as it is a secondary analysis
of publicly-available data.
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Results
Observed/diagnosed prevalence of CVD
Observed (O) and expected (E) prevalence summary sta-
tistics are shown in Table 1. Total English population
was used as the denominator for consistency with stan-
dard reporting of QOF prevalence. The mean prevalence
of QOF-diagnosed CHD in LAs was 2.57% (95% CIs
2.45-2.69), and the expected prevalence was 4.52% (95%
CIs 4.42-4.61), giving an O:E ratio of 0.57 i.e. about 60
per cent of expected cases are diagnosed. Although the
prevalence of stroke is less than half that of CHD, the O:
E ratio is very similar. The expected prevalence of hyper-
tension is much higher (about 24% of over 16s), and the
O:E ratio is only 0.37 i.e. less than 40% of cases may be
diagnosed. There was wide variation in the O:E ratio
between LAs, with less than five per cent of expected
cases diagnosed in some areas for all three diseases.
Spatial analysis
Mapping of observed and expected prevalence demon-
strated that observed and predicted prevalence for both
diseases showed strong north-south and southwest-
southeast gradients, with the southeast generally show-
ing lowest disease levels, especially in the case of
expected prevalence. However, within these geographical
trends in both QOF and modelled prevalence, mapping
of O:E ratios demonstrated spatial variation between
neighbouring LAs. LMI Z scores indicated the presence
of some statistically significant clusters and outliers in
O:E ratios (Figure 1, Figure 2 and Figure 3).
For all three conditions, particularly CHD and stroke,
London and much of its hinterland showed statistically
significant discrepancies in O:E ratios, with observed
prevalence much lower than the epidemiological models
predicted. For CHD there were also significant clusters
and outliers in parts of northern England, especially in
Cumbria and Yorkshire, though unlike for the London
area the clusters typically related to O:E ratios tending
towards unity.
Further geographic analysis with GWR revealed signif-
icant spatial variation in the O:E relationship for CHD,
hypertension and stroke, with GWR describing the data-
set more accurately than traditional OLS regression.
The linearity of the relationship between observed and
expected prevalence was weakest for hypertension with
the lowest overall regression coefficients and highest
residual sum of squares for observed against expected
prevalence; stronger associations were observed for
CHD and stroke.
Even maximum coefficient values for hypertension,
found along the south and east coasts, were less than
0.26; coefficients were lowest in the north and a pro-
nounced north-south gradient was observed. The
pattern for stroke was somewhat more complex with
coefficients typically less than 0.21 for much of the
northern parts of the country and the Midlands, yet
with parts of Kent and the Sussex Counties having coef-
ficients up to 0.69. CHD followed a similar geographic
structure to stroke, with values of less than 0.08 for
much of the Midlands and north, yet rising to 0.66 in
eastern and southern coastal areas. There were no statis-
tically significant patterns in Cook’s D and standardised
residual results for any of the three conditions exam-
ined. However, although O:E ratios tended towards 1 in
the north and declined further south, the GWR results
showed that the predictability of the relationship
between observed and expected prevalence decreased
with an increasing latitude. The addition of GP supply
as a variable yielded stronger regression results for all
three conditions (Table 2).
Discussion
Main findings
The findings presented here indicate that despite almost
universal access to free primary healthcare services, and
a significant financial incentive for these services to find
and register new cases on their computer systems, there
may be significant under-diagnosis of all three CVD
conditions examined in this study in many areas in Eng-
land. The difference between expected and recorded dis-
ease is most marked for hypertension, with strikingly
wide variation in diagnosis levels between areas. Hyper-
tension and stroke showed similar geographic variation
to CHD, but without the clusters/outliers for northern
England; additionally the contrast between the ratios for
London and LAs immediately to the north was more
pronounced for stroke.
An obvious question is: why was there such a discre-
pancy between expected and practice-registered disease
prevalence, when the model-based CHD and stroke pre-
valence estimates were based on patient reports of doc-
tor-diagnosed disease? Reasons why practice computer
systems may under-record cases are likely to include
inadequate searching of practice records (which are now
in the UK mainly electronic) for previous diagnoses or
CVD-related prescriptions [28,29], lack of linkage of
practice and hospital records (practice still have to enter
codes for hospital admissions manually), and high popu-
lation mobility in urban areas: data for new patients is
often still entered into practice systems manually and
previous diagnoses may not be added for some time
[30]. The QOF does not appear to have resulted in sub-
stantial improvement in recording. The crude QOF
CHD prevalence was 3.44% in 2006-7, the year after
QOF was implemented, but was 3.54% in 2009/10 - a
minimal increase. In the case of hypertension, for which
Soljak et al. BMC Cardiovascular Disorders 2011, 11:12
http://www.biomedcentral.com/1471-2261/11/12
Page 4 of 11
Table 1 observed (GP-registered) and expected/modelled prevalence summary statistics
Coronary Heart Disease Hypertension Stroke
Observed
Prevalence
Expected
Prevalence
O:E
Ratio
Observed
Prevalence
Expected
Prevalence
Observed: Expected
Ratio
Observed
Prevalence
Expected
Prevalence
O:E
Ratio
Number 1,299,601 2,286,597 4,530,369 12,356,995 588,500 1,009,144
Prevalence rate/Percent
(95% CIs)1
2.57%
(2.45%-2.69%)
4.52%
(4.42%-4.61%)
0.57
(0.55-
0.59)
8.95%
(8.59%-9.32%)
24.42%
(24.13%-24.72%)
0.37
(0.35-0.38)
1.16%
(1.11%-1.22%)
1.99%
(1.96-2.03%)
0.58
(0.56-
0.61)
Median 2.40% 4.48% 0.55 8.77% 24.77% 0.36 1.11% 1.99% 0.57
Maximum 5.47% 7.78% 1.10 16.62% 35.17% 0.63 2.48% 3.26% 1.08
Minimum 0.14% 2.61% 0.04 0.57% 17.71% 0.02 0.06% 1.24% 0.03
1st quartile 1.56% 3.89% 0.38 5.92% 23.06% 0.25 0.74% 1.77% 0.40
3rd quartile 3.31% 5.10% 0.69 11.10% 26.75% 0.43 1.49% 2.23% 0.73
Interquartile range 1.75% 1.22% 0.32 5.18% 3.69% 0.18 0.75% 0.47% 0.33
Standard deviation 0.011 0.009 0.21 0.035 0.028 0.13 0.005 0.004 0.22
1The England population denominator used for all three diseases was 50,598,200.
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Figure 1 Clusters and outliers in observed to expected ratios for CHD (red indicates clusters and blue indicates outliers).
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Figure 2 Clusters and outliers in observed to expected ratios for hypertension (red indicates clusters and blue indicates outliers).
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Figure 3 Clusters and outliers in observed to expected ratios for stroke (red indicates clusters and blue indicates outliers).
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the modelled estimates used a combination of doctor-
diagnosed disease and blood pressure measurements,
the gap is greatest in younger and middle age groups,
when males in particular are less likely to be seen by
their practices [31]. In contrast, diagnosis appears to be
more complete in the north of England.
From a spatial analytic perspective, there are signifi-
cant geographic discrepancies between QOF prevalence
and modelled prevalence for all three conditions in
much of London and its hinterland. The inclusion of a
measure of GP supply in the GWR analyses suggests
that, despite needs-based healthcare resource allocation
in the UK, persistent differences in availability of pri-
mary care services is an important limiting factor in
diagnosis. An analysis of Gini coefficients to measure
geographical equity in GPs per 100,000 population in
England and Scotland showed that equity in England
rose between 1974 and 1994, but then decreased, and in
2006 it was below the 1974 level [32].
The results also provide some contrast to a study
investigating revascularisation rates in males, which
found that even after adjusting for the higher CHD bur-
den in the north of the country related to socio-demo-
graphic composition, the likelihood of receiving surgery
during the 1990s decreased outside of southern England,
suggesting a geographic imbalance in the provision of
tertiary cardiology care [33]. Considerable efforts have
been made subsequently to ensure that access to tertiary
care is more equitable. However our analysis suggests
that from a primary care perspective, it is London and
the surrounding area which would benefit most from
increased resource allocation, although GP supply itself
seems to be only one influential factor affecting diagno-
sis levels. Further work will need to investigate the
Table 2 comparison of classical regression and GWR results
CHD Classical regression GWR
O against E O = E+GP O against E O = E+GP
Residual sum of squares 0.032 0.026 0.026 0.017
Standard deviation 0.010 0.009 0.009 0.007
Akaike Information Criterion -2260.43 -2336.25 -2285.75 -2393.81
Correlation coefficient 0.299 0.439 0.427 0.637
Adjusted correlation coefficient 0.295 0.434 0.387 0.585
Sum of squares 0.0 0.0 0.0 0.0
Degrees of freedom 2.00 3.00 328.09 306.86
Hypertension Classical regression GWR
O against E O = E+GP O against E O = E+GP
Residual sum of squares 0.374 0.250 0.362 0.241
Standard deviation 0.033 0.027 0.032 0.026
Akaike Information Criterion -1400.41 -1539.57 -1403.50 -1543.67
Correlation coefficient 0.121 0.412 0.150 0.432
Adjusted correlation coefficient 0.116 0.407 0.134 0.421
Sum of squares 0.4 0.2 0.4 0.2
Degrees of freedom 2.00 3.00 344.87 344.04
Stroke Classical regression GWR
O against E O = E+GP O against E O = E+GP
Residual sum of squares 0.007 0.006 0.005 0.003
Standard deviation 0.004 0.004 0.004 0.003
Akaike Information Criterion -2807.25 -2873.16 -2838.92 -2932.93
Correlation coefficient 0.262 0.392 0.422 0.621
Adjusted correlation coefficient 0.258 0.387 0.374 0.561
Classical regression GWR
O against E O = E+GP O against E O = E+GP
Sum of squares 0.0 0.0 0.0 0.0
Degrees of freedom 2.00 3.00 324.37 302.87
O against E: ratio of observed against expected prevalence.
O = E+GP: inclusion of GP supply as an additional independent variable.
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effectiveness and yield of strategies for CVD case-finding
by practices, and to validate the predictions of the pre-
valence models at practice level.
Strengths and limitations of the study
Strengths of the study include the use of new data from
practice disease registers and recently-developed geogra-
phical analytical techniques and software. Limitations
include the fact that modelling was carried out at LA level,
which may conceal much wider variation at lower levels.
The spatial scale of the analyses includes many LAs which
are highly heterogeneous in socio-demographic composi-
tion, so the study may have missed significant small area
variation; this is especially likely in northern areas where
regression associations were weakest. There is imprecision
in the model prevalence estimates, for example, because of
the size of the Health Survey sample we used, especially in
subgroups with small numbers of cases - the precision of
the estimates is also affected by the prevalence of the dis-
ease outcomes. Model restrictions include that the propor-
tion of smokers, ex-smokers and never-smokers is uniform
across ethnic categories, when, for example, smoking pre-
valence varied from 16.4% in the Black/Black British sam-
ple population to 24.1% in the White sample population.
Smoking prevalence is itself a modelled estimate, and ex-
smoking prevalence is assumed to be the same nationwide.
In addition the number of variables in the local prevalence
models is constrained by the availability of local data on
risk factors, so that it is not possible to include other well-
established CVD risk factors as variables. Some of the
local risk factor data relies on estimates based on 2001
Census data, although this will be improved by, for exam-
ple, more accurate and timely data on smoking prevalence
from the new ONS Integrated Household Survey. How-
ever we were reassured by the results of model validation,
e.g. ROC curves. In addition, comparing model predictions
to QOF registrations is also a form of external validation.
For example, QOF registered counts of CHD were greater
than expected counts in only three of 352 LAs, and in
these only by small amounts. If the models were very
imprecise, much more under-estimation would be
expected. Further model validation is needed, and is
occurring as the models are being used to guide local
case-finding initiatives.
Conclusions
Despite the absence of barriers to primary healthcare,
there is likely to be significant and highly variable
under-diagnosis of CVD across England, which can be
partially explained by persistent inequity in GP supply.
However, the distinctive composition and dynamics of
London’s population probably adds complexities to the
identification of CVD in that region. Studies of disease
management should consider the impact of this
“iceberg” of undiagnosed disease on hospital utilisation
and population health outcomes. Spatial analytic techni-
ques can provide additional information about geogra-
phical variation compared to classical regression
modelling, and can suggest where more healthcare
resources may be most needed.
Data sharing
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